MyFinsight
Home
Blog
About
Contact
Download
Download image
Net loss
-$13,063,512
Loss before income
taxes
-$13,062,674
Income tax provision
$838
Loss from operations
-$13,062,674
Total operating
expenses
$13,062,674
Research and development
(including 10,125,000 for...
$10,248,545
General and
administrative
$2,814,129
Back
Back
Income Statement
source: myfinsight.com
Estrella Immunopharma, Inc. (ESLA)
Estrella Immunopharma, Inc. (ESLA)